1560
Y. Uozumi et al.
CLUSTER
(6) For studies on heterogeneous aquacatalytic asymmetric p-
allylic transformations with polymer-supported complex
catalysts in water, see: (a) Alkylation: Uozumi, Y.; Danjo,
H.; Hayashi, T. Tetrahedron Lett. 1998, 39, 8303. (b)
Reduction with monodentate phosphine (MOP): Hocke, H.;
Uozumi, Y. Tetrahedron 2004, 60, 9297. (c) Alkylation:
Uozumi, Y.; Shibatomi, K. J. Am. Chem. Soc. 2001, 123,
2919. (d) Amination: Uozumi, Y.; Tanaka, H.; Shibatomi,
K. Org. Lett. 2004, 6, 281. (e) Cyclization: Nakai, Y.;
Uozumi, Y. Org. Lett. 2005, 7, 291. (f) Etherification:
Uozumi, Y.; Kimura, M. Tetrahedron: Asymmetry 2006, 17,
161. (g) Nitromethylation: Uozumi, Y.; Suzuka, T. J. Org.
Chem. 2006, 71, 8644. (h) Kobayashi, Y.; Tanaka, D.;
Danjo, H.; Uozumi, Y. Adv. Synth. Catal. 2006, 348, 1561.
(i) Uozumi, Y. Pure Appl. Chem. 2007, 79, 1481.
(7) For recent reviews on asymmetric p-allylic substitution,
see: (a) Acemoglu, L.; Williams, J. M. J. Handbook of
Organopalladium Chemistry for Organic Synthesis;
Negishi, E.; de Meijere, A., Eds.; Wiley: New York, 2002.
(b) Trost, B. M.; Crawley, M. L. Chem. Rev. 2003, 103,
2921.
(dt, J = 7.3, 14.6 Hz, 1 H), 2.05 (s, 3 H), 1.89 (dt, J = 4.0,
14.6 Hz, 1 H). 13C NMR (CDCl3): d = 170.77, 157.77,
135.05, 134.06, 129.53, 115.34, 79.55, 76.74, 37.94, 21.08.
IR (ATR): 1733, 1493, 1366, 1228, 1087, 889, 754, 692, 628
cm–1. MS (EI): m/z (%rel intensity) = 218 (0.7) [M+], 43
(base peak). Anal. Calcd for C13H14O3: C, 71.54; H, 6.47.
Found: C, 71.49; H, 6.53. CAS registry number: 210701-
09-0.
1-Acetoxy-4-(2-benzyloxyphenoxy)-2-cyclopentene (6b):
[a]D28 –20.5 (c = 1.0, CHCl3); 97% ee. 1H NMR (CDCl3):
d = 7.43–7.27 (m, 4 H), 6.89–6.98 (m, 5 H), 6.26 (br d, J =
4.8 Hz, 1 H), 6.09 (br d, J = 4.8 Hz, 1 H), 5.57 (br, 1 H), 5.17
(br, 1 H), 5.12 (s, 2 H), 2.93 (dt, J = 7.3, 14.6 Hz, 1 H), 2.04
(s, 3 H), 1.98 (dt, J = 4.3, 14.6 Hz, 1 H). 13C NMR (CDCl3):
d = 170.88, 149.49, 148.28, 137.32, 134.67, 133.73, 128.45,
127.78, 127.29, 122.21, 121.70, 117.09, 115.60, 81.72,
76.79, 71.31, 38.08, 21.13. IR (ATR): 1732, 1499, 1452,
1366, 1236, 1212, 1083, 1012, 896, 742, 697, 627 cm–1. MS
(EI): m/z (%rel intensity) = 324 (1) [M+], 91 (base peak).
Anal Calcd for C20H20O4: C, 74.06; H, 6.21. Found: C,
73.94; H, 6.28.
26
(8) (a) Taniimori, S.; Tsuji, Y.; Kirihara, M. Biosci.,
Biotechnol., Biochem. 2002, 66, 660. (b) Song, E. S.; Yang,
J. W.; Roh, E. J.; Lee, S.-G.; Han, H. Angew. Chem. Int. Ed.
2002, 41, 3852. (c) Trost, B. M.; Van Vranken, D. L.;
Bingel, C. J. Am. Chem. Soc. 1992, 114, 9327.
1-Acetoxy-4-(2-chlorophenoxy)-2-cyclopentene(6c):[a]D
–58.0 (c = 1.0, CHCl3). 1H NMR (CDCl3): d = 7.37 (dd, J =
1.8, 7.9 Hz, 1 H), 7.20 (dt, J = 1.8, 7.9 Hz, 1 H), 6.95 (d, J =
7.9 Hz, 1 H), 6.92 (t, J = 7.9 Hz, 1 H), 6.26 (d, J = 5.5 Hz, 1
H), 6.14 (J = 5.5 Hz, 1 H), 5.60 (br, 1 H), 5.17 (br, 1 H), 2.99
(dt, J = 7.3, 14.6 Hz, 1 H), 2.06 (s, 3 H), 1.96 (dt, J = 4.3,
14.6 Hz, 1 H). 13C NMR (CDCl3): d = 170.84, 153.65,
134.65, 134.46, 130.57, 127.66, 123.71, 121.94, 115.26,
81.33, 76.61, 38.02, 21.11. IR (ATR): 1237, 1090, 902, 730,
649, 630 cm–1. MS (EI): m/z (%rel intensity): = 252 (0.02)
[M+], 43 (base peak).
(9) Trost B. M., Pulley S. R., Bingel C.; Tetrahedron Lett.;
1995, 36: 8737.
(10) Tenta Gel SNH2 (purchased from Rapp Polymere) was used
as the polymer support.
(11) Chemical yield of the monosubstituted product 4 was
lowered to <30% with Li2CO3, NaHCO3, Na2CO3, or
K2CO3.
(12) The absolute configuration of 4 was determined by chemical
correlation with (1R,4S)-cis-1-acetoxy-4-[bis(methoxy-
carbonyl)methyl]-2-cyclopentene (see ref. 8a).
(13) Nishiyama, H.; Sakata, N.; Sugimoto, H.; Motoyama, Y.;
Wakita, H.; Nagase, H. Synlett 1998, 930.
(14) The absolute configuration of 6a was determined to be 1R,4S
by measurement of the specific rotation (see, ref. 12). The
configurations of 6b–g were tentatively assigned on the
basis of the mechanistic similarity of the asymmetric
induction, as depicted in Table 1.
(15) Palladium-Catalyzed Asymmetric Desymmetrization of
meso-Cycloalkene-1,4-diacetate: Reaction conditions and
results are shown in Table 1. A typical procedure is given for
the reaction with cis-1,4-diacetoxycyclopentene (meso-2)
and phenol (a) in H2O (entry 3).
1-Acetoxy-4-(2-bromophenoxy)-2-cyclopentene (6d):
[a]D25 –100.8 (c = 1.1, CHCl3); 95% ee. 1H NMR (CDCl3):
d = 7.55 (dd, J = 1.2, 7.9 Hz, 1 H), 7.25 (td, J = 1.2, 7.3 Hz,
1 H), 6.94 (d, J = 1.2 Hz, 1 H), 6.85 (td, J = 1.2, 7.9 Hz, 1 H),
6.26 (d, J = 5.5 Hz, 1 H), 6.14 (d, J = 5.5 Hz, 1 H), 5.60 (br
t, J = 5.5 Hz, 1 H), 5.17 (br t, J = 5.5 Hz, 1 H), 2.07 (s, 3 H),
2.00 (dt, J = 7.3, 14.6 Hz, 1 H), 1.96 (dt, J = 4.2, 14.6 Hz, 1
H). 13C NMR (CDCl3): d = 170.79, 154.52, 134.60, 134.39,
133.61, 128.37, 122.34, 114.99, 113.00, 81.34, 76.55, 38.00,
21.07. IR (ATR): 1733, 1584, 1573, 1474, 1442, 1366, 1085,
1029, 895, 748, 627 cm–1. MS (EI): m/z (%rel intensity) =
296 (0.02) [M+], 43 (base peak). Anal. Calcd for
C13H13BrO3: C, 52.55; H, 4.41. Found: C, 52.37; H, 4.37.
1-Acetoxy-4-(2,6-dimethylphenoxy)-2-cyclopentene (6e):
[a]D27 –41.4 (c = 1.1, CHCl3). 1H NMR (CDCl3): d = 7.02 (d,
J = 7.3 Hz, 2 H), 6.92 (t, J = 7.3 Hz, 1 H), 6.16 (d, J = 5.4
Hz, 1 H), 6.05 (d, J = 5.4 Hz, 1 H), 5.52 (br t, J = 4.4 Hz, 1
H), 4.81 (br t, J = 6.3 Hz, 1 H), 2.88 (dt, J = 7.3, 14.6 Hz, 1
H), 2.30 (s, 6 H), 2.09 (s, 3 H), 2.06 (dt, J = 4.4, 14.6 Hz, 1
H). 13C NMR (CDCl3): d = 171.09, 155.79, 136.60, 133.37,
131.06, 129.16, 123.95, 84.66, 76.73, 38.51, 21.39, 17.46.
IR (ATR): 1730, 1365, 1237, 1198, 1091, 903, 730, 649, 630
cm–1. MS (EI): m/z (%rel intensity) = 246 (0.09) [M+], 43
(base peak). HRMS (EI): m/z [M+] calcd for C15H18O3:
246.1256; found: 246.1251. The enantiomeric excess was
determined by HPLC analysis using a chiral stationary phase
column [Chiralcel OD-H, eluent: n-hexane–2-propanol,
50:1; flow rate: 0.5 mL/min; tR (major isomer) = 14.73 min
and tR (minor isomer) = 13.98 min] to be 90% ee.
To a mixture of the catalyst 1 (89 mg, 0.025 mmol) and
meso-2 (92 mg, 0.5 mmol) in H2O (2.5 mL) was added
phenol (48 mg, 0.5 mmol), and the mixture was shaken at
0 °C for 18 h. The reaction mixture was filtered and the
recovered resin beads were rinsed with EtOAc (3 ×). The
combined filtrate was dried over anhyd Na2SO4. The solvent
was evaporated and the residue was chromatographed on
silica gel (hexane–EtOAc, 10:1) to give 1-acetoxy-4-
phenoxycyclopentene (6a; 70 mg, 64% yield) and 1,4-
diphenoxycyclopentene (8; 18 mg). The enantiomeric
excess was determined to be 99% ee by GC analysis using a
chiral stationary phase capillary column (Cyclodex CB).
Spectral and analytical data for compounds 6 are shown
below, where the enantiomeric excesses were determined by
GC (Cyclodex CB), unless otherwise noted: 1-Acetoxy-4-
phenoxycyclopentene (6a): [a]D23 +63.8 (c = 1.0, CHCl3). 1H
NMR (CDCl3): d = 7.29 (t, J = 7.8 Hz, 2 H), 6.96 (t, J = 7.3
Hz, 1 H), 6.92 (d, J = 7.8 Hz, 2 H), 6.24 (d, J = 5.8 Hz, 1 H),
6.12 (d, J = 5.3 Hz, 1 H), 5.61 (br, 1 H), 5.17 (br, 1 H), 2.97
1-Acetoxy-4-(3-methoxyphenoxy)-2-cyclopentene (6f):
[a]D26 +57.5 (c = 1.1, CHCl3); 96% ee. 1H NMR (CDCl3):
d = 7.18 (t, J = 8.5 Hz, 1 H), 6.52 [td, J = 2.4, 8.5 Hz
(overlapped), 2 H], 6.48 (t, J = 2.4 Hz, 1 H), 6.24 (d, J = 5.5
Hz, 1 H), 6.13 (d, J = 5.5 Hz, 1 H), 5.60 (br, 1 H), 5.16 (br,
1 H), 3.78 (s, 3 H), 2.96 (dt, J = 7.3, 14.6 Hz, 1 H), 2.05 (s,
Synlett 2008, No. 10, 1557–1561 © Thieme Stuttgart · New York